Automated Sample Storage Systems Market Size, Share & Trends Analysis Report By Product (Automated Compound Storage Systems, Automated Liquid Handling Systems, Others), By Sample, By End Use, By Region, And Segment Forecasts, 2026 - 2033
Description
Automated Sample Storage Systems Market Summary
The global automated sample storage systems market size was estimated at USD 1.71 billion in 2025 and is projected to reach USD 4.11 billion by 2033, growing at a CAGR of 12.07% from 2026 to 2033. Increasing investments in the pharmaceutical and biopharmaceutical sectors are expected to drive the global market for automated sample storage systems.
Moreover, the rising demand for automation across industries to reduce labor costs and increase process efficiency further fuels industry uptake. The growing adoption of automated sample management systems is driven by the need for increased throughput, enhanced sample integrity, and reduced human error in laboratories. These systems streamline sample handling, enhance traceability, and enable efficient integration with LIMS and laboratory automation workflows. The increasing demand in biobanking, pharmaceutical R&D, and clinical diagnostics further accelerates their adoption, supporting faster decision-making and enhanced regulatory compliance.
Growth in Biobanking and Life Science
The rapid expansion of biobanking and life sciences research is a key driver fueling demand for automated sample storage systems worldwide. With the rise of high-throughput research in genomics, proteomics, metabolomics, and cell biology, research institutions and pharmaceutical companies are generating and handling vast quantities of biological samples. For instance, in February 2025, the UK Biocentre launched Azenta’s automated BioArc Ultra −80 °C storage system in the UK, enhancing sample preservation, sustainability, and operational efficiency across its biobanking operations. These samples, ranging from DNA and RNA to plasma, tissue and cell cultures, require long-term preservation under strictly controlled conditions to maintain their stability and research value. Manual storage methods are increasingly inadequate for managing such scale and complexity, especially in large biobanks that may house millions of samples. Automated storage systems provide the necessary infrastructure to store, organize, and retrieve specimens with speed, precision, and minimal human error, allowing researchers to focus more on scientific discovery and less on operational logistics.
Moreover, maintaining sample integrity and traceability is critical for scientific validity and regulatory compliance. Automated systems offer superior environmental control. This ensures full traceability and minimizes the risks of contamination, mislabeling, or degradation caused by manual handling. As life sciences increasingly converge with data-intensive technologies like AI and machine learning, accessing high-quality, well-preserved biological samples at scale becomes a competitive advantage. These factors are accelerating investment in automated sample storage infrastructure across academic research centers, pharmaceutical R&D pipelines, and commercial biobanks, making it a central enabler for the next generation of biomedical innovation.
Global Automated Sample Storage Systems Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global automated sample storage systems market report on the basis of product, sample, end use, and region:
The global automated sample storage systems market size was estimated at USD 1.71 billion in 2025 and is projected to reach USD 4.11 billion by 2033, growing at a CAGR of 12.07% from 2026 to 2033. Increasing investments in the pharmaceutical and biopharmaceutical sectors are expected to drive the global market for automated sample storage systems.
Moreover, the rising demand for automation across industries to reduce labor costs and increase process efficiency further fuels industry uptake. The growing adoption of automated sample management systems is driven by the need for increased throughput, enhanced sample integrity, and reduced human error in laboratories. These systems streamline sample handling, enhance traceability, and enable efficient integration with LIMS and laboratory automation workflows. The increasing demand in biobanking, pharmaceutical R&D, and clinical diagnostics further accelerates their adoption, supporting faster decision-making and enhanced regulatory compliance.
Growth in Biobanking and Life Science
The rapid expansion of biobanking and life sciences research is a key driver fueling demand for automated sample storage systems worldwide. With the rise of high-throughput research in genomics, proteomics, metabolomics, and cell biology, research institutions and pharmaceutical companies are generating and handling vast quantities of biological samples. For instance, in February 2025, the UK Biocentre launched Azenta’s automated BioArc Ultra −80 °C storage system in the UK, enhancing sample preservation, sustainability, and operational efficiency across its biobanking operations. These samples, ranging from DNA and RNA to plasma, tissue and cell cultures, require long-term preservation under strictly controlled conditions to maintain their stability and research value. Manual storage methods are increasingly inadequate for managing such scale and complexity, especially in large biobanks that may house millions of samples. Automated storage systems provide the necessary infrastructure to store, organize, and retrieve specimens with speed, precision, and minimal human error, allowing researchers to focus more on scientific discovery and less on operational logistics.
Moreover, maintaining sample integrity and traceability is critical for scientific validity and regulatory compliance. Automated systems offer superior environmental control. This ensures full traceability and minimizes the risks of contamination, mislabeling, or degradation caused by manual handling. As life sciences increasingly converge with data-intensive technologies like AI and machine learning, accessing high-quality, well-preserved biological samples at scale becomes a competitive advantage. These factors are accelerating investment in automated sample storage infrastructure across academic research centers, pharmaceutical R&D pipelines, and commercial biobanks, making it a central enabler for the next generation of biomedical innovation.
Global Automated Sample Storage Systems Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global automated sample storage systems market report on the basis of product, sample, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Automated Compound Storage System
- Automated Liquid Handling Systems
- Others
- Sample Outlook (Revenue, USD Million, 2021 - 2033)
- Biological Samples
- Compound Samples
- Others
- End-user Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical and Biotech Companies
- Academic and Research Institutions
- Biobanks
- Others
- Regional Outlook (Revenue, USD Million, 2021- 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Application Segment
- 1.2.3. End Use
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
- Chapter 3. Lactate Monitoring Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising incidence of sepsis and critical illnesses
- 3.2.1.2. Growing use in sports and fitness performance
- 3.2.1.3. Advancements in point-of-care and wearable technologies
- 3.2.1.4. Expanding use in surgical and post operative monitoring
- 3.2.2. Market restraint analysis
- 3.2.2.1. Limited penetration in low-resource healthcare settings
- 3.2.2.2. Clinical reliance on broader blood gas panels
- 3.3. Lactate Monitoring Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.2.4. Environmental Landscape
- 3.3.2.5. Legal Landscape
- 3.3.2.6. Social Landscape
- 3.4. Clinical Trials of Lactate Monitoring Devices for Medical Application
- Chapter 4. Lactate Monitoring Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Lactate Monitoring Devices Market Product Movement Analysis
- 4.3. Global Lactate Monitoring Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Chargeable Lactate Meters
- 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5. Battery Operated Lactate Meters
- 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 5. Lactate Monitoring Devices Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Lactate Monitoring Devices Market Application Movement Analysis
- 5.3. Global Lactate Monitoring Devices Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Sports
- 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.5. Medical
- 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 6. Lactate Monitoring Devices Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Lactate Monitoring Devices Market End Use Movement Analysis
- 6.3. Global Lactate Monitoring Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Hospitals & Clinics
- 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.5. Sports Institutes
- 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.6. Home Care
- 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.7. Others
- 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 7. Lactate Monitoring Devices Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 7.4. North America
- 7.4.1. U.S.
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework
- 7.4.1.3. Competitive scenario
- 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.2. Canada
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.3. Mexico
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5. Europe
- 7.5.1. UK
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework
- 7.5.1.3. Competitive scenario
- 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.2. Germany
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.3. France
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.4. Italy
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.5. Spain
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.6. Norway
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.8. Denmark
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Regulatory framework
- 7.5.8.3. Competitive scenario
- 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Japan
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.2. China
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.3. India
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.4. Australia
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework
- 7.6.5.3. Competitive scenario
- 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.7. New Zealand
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework
- 7.6.7.3. Competitive scenario
- 7.6.7.4. New Zealand market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.8. Singapore
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework
- 7.6.8.3. Competitive scenario
- 7.6.8.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Brazil
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7.2. Argentina
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8. MEA
- 7.8.1. South Africa
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework
- 7.8.1.3. Competitive scenario
- 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8.2. Saudi Arabia
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8.3. UAE
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework
- 7.8.3.3. Competitive scenario
- 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8.4. Kuwait
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Regulatory framework
- 7.8.4.3. Competitive scenario
- 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.8.5. Qatar
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Regulatory framework
- 7.8.5.3. Competitive scenario
- 7.8.5.4. Qatar market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2025
- 8.4. Company Profiles/Listing
- 8.4.1. Nova Biomedical
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. ARKRAY, Inc.
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. EKF Diagnostics
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. TECOM Analytical Systems
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Sensa Core Medical
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. VivaCheck Biotech
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. ApexBio
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. TaiDoc Technology Corporation
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
